1. Adli M, Baethge C, Heinz A, Langlitz N, Bauer M (2005) Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review. Eur Arch Psychiatry Clin Neurosci 255(6):387–400. https://doi.org/10.1007/s00406-005-0579-5
2. Alevizos B, Alevizos E, Leonardou A, Zervas I (2012) Low dosage lithium augmentation in venlafaxine resistant depression: an open-label study. Psychiatriki 23(2):143–148
3. Alvarez E, Pérez-Solá V, Pérez-Blanco J, Queraltó J, Torrubia R, Noguera R (1997) Predicting outcome of lithium added to antidepressants in resistant depression. J Affect Disord 42(2–3):179–186
4. Amare AT, Schubert KO, Hou L, Clark SR, Papiol S, Heilbronner U, Degenhardt F, Tekola-Ayele F, Hsu Y-H, Shekhtman T (2018) Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: a genome-wide association study. JAMA psychiatry 75(1):65–74
5. Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M (2014) Role of lithium augmentation in the management of major depressive disorder. CNS drugs 28(4):331–342